Verdon, Rhyza Mae M.

HRN: 10-46-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2025
CEFUROXIME 750MG (VIAL)
11/12/2025
11/19/2025
IV
750mg
Q8hours
PCAP-C
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  PneumoniaCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: